These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay. Bostic JR, Brown KE, Young NS, Koenig S. J Infect Dis; 1999 Mar; 179(3):619-26. PubMed ID: 9952368 [Abstract] [Full Text] [Related]
3. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood. Lehmann HW, Knöll A, Küster RM, Modrow S. Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831 [Abstract] [Full Text] [Related]
4. CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection. Lindner J, Barabas S, Saar K, Altmann D, Pfister A, Fleck M, Deml L, Modrow S. J Vet Med B Infect Dis Vet Public Health; 2005 Jun; 52(7-8):356-61. PubMed ID: 16316401 [Abstract] [Full Text] [Related]
8. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Von Landenberg P, Lehmann HW, Knöll A, Dorsch S, Modrow S. Arthritis Rheum; 2003 Jul 01; 48(7):1939-47. PubMed ID: 12847688 [Abstract] [Full Text] [Related]
9. The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production. Tzang BS, Tsay GJ, Lee YJ, Li C, Sun YS, Hsu TC. Clin Chim Acta; 2007 Mar 01; 378(1-2):59-65. PubMed ID: 17169353 [Abstract] [Full Text] [Related]
13. Diagnostic of parvovirus B19 infection. Schwarz TF, Roggendorf M. Behring Inst Mitt; 1990 Aug 01; (85):35-8. PubMed ID: 2171483 [Abstract] [Full Text] [Related]
14. IgG immune response to B19 parvovirus VP1 and VP2 linear epitopes by immunoblot assay. Manaresi E, Gallinella G, Zerbini M, Venturoli S, Gentilomi G, Musiani M. J Med Virol; 1999 Feb 01; 57(2):174-8. PubMed ID: 9892404 [Abstract] [Full Text] [Related]
15. Establishment of functional B cell memory against parvovirus B19 capsid proteins may be associated with resolution of persistent infection. Corcoran A, Crowley B, Dewhurst C, Pizer BL, Doyle S. J Med Virol; 2006 Jan 01; 78(1):125-8. PubMed ID: 16299723 [Abstract] [Full Text] [Related]
18. Adaptive immune responses against parvovirus B19 in patients with myocardial disease. Lindner J, Noutsias M, Lassner D, Wenzel J, Schultheiss HP, Kuehl U, Modrow S. J Clin Virol; 2009 Jan 01; 44(1):27-32. PubMed ID: 18980860 [Abstract] [Full Text] [Related]
19. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection. Pfrepper KI, Enders M, Motz M. J Vet Med B Infect Dis Vet Public Health; 2005 Jan 01; 52(7-8):362-5. PubMed ID: 16316402 [Abstract] [Full Text] [Related]
20. [Comparative study of indirect immunofluorescence (IIF) and ELISA techniques in the detection of parvovirus B19]. González M, Hassanhi M, Rivera S, Bracho MP. Invest Clin; 2000 Mar 01; 41(1):19-27. PubMed ID: 10758696 [Abstract] [Full Text] [Related] Page: [Next] [New Search]